A theory for polymicrogyria and brain arteriovenous malformations in HHT
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Hereditary hemorrhagic telangiectasia (HHT) is generally considered a disorder of endothelial dysfunction, characterized by the development of multiple systemic arteriovenous malformations (AVMs), including within the brain. However, there have recently been a number of reports correlating HHT with malformations of cortical development, of which polymicrogyria is the most common type. Here we present 7 new cases demonstrating polymicrogyria in HHT, 6 of which demonstrate a brain AVM (bAVM) in close spatial proximity, with the aim of providing a common origin for the association. Upon reviewing patient genetics and imaging data and comparing with previously reported findings, we form 2 new conclusions: (1) polymicrogyria in HHT appears exclusively associated with a subset of mutations in the transmembrane protein endoglin that is involved with blood flow–related mechanotransduction signaling during angiogenesis and (2) the polymicrogyria is characteristically unilateral, typically focal, and correlates with vascular regions experiencing low fluid shear stress during corticogenesis in utero. Integrating these with findings in the literature from genetics and molecular biology experiments, we propose a theory suggesting haploinsufficient endoglin mutations, especially those that are dominant-negative, may predispose focal, aberrant hypersprouting angiogenesis during corticogenesis that leads to the production of polymicrogyria. This hypoxic insult may further serve as the revealing trigger for later development of a spatially coincident bAVM. This hypothesis suggests an essential role for endoglin-mediated hemodynamic mechanotransduction in normal corticogenesis.
Glossary
- ALK1=
- activin receptor-like kinase 1;
- bAVM=
- brain arteriovenous malformation;
- BMP=
- bone morphogenetic protein;
- DN=
- dominant-negative;
- EC=
- endothelial cell;
- FSS=
- fluid shear stress;
- HHT=
- hereditary hemorrhagic telangiectasia;
- MCD=
- malformations of cortical development;
- pAVM=
- pulmonary arteriovenous malformation;
- SC=
- stalk cell;
- TC=
- tip cell;
- TGFβ=
- transforming growth factor β;
- VEGFA=
- vascular endothelial growth factor A;
- VoGM=
- vein of Galen malformation;
- vSMC=
- vascular smooth muscle cells;
- WT=
- wild-type
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received March 27, 2018.
- Accepted in final form August 14, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Glossary
- Phenotype and genotype of observed lesions
- Comparison with previous reported findings
- Postulate 1: Polymicrogyria in HHT1 reflects in utero cerebral hypoxia
- Postulate 2: HHT1 endothelial dysfunction produces a suboptimal response to in utero cerebral hypoxia
- The importance of HHT1 dominant-negative haploinsufficiency
- Postulate 3: Focal hypoxia from hypersprouting angiogenesis may also provide a trigger for bAVM development
- Other less favored mechanisms for cerebral in utero ischemia
- Discussion
- Author contributions
- Study funding
- Disclosure
- Footnotes
- References
- Figures & Data
- Info & Disclosures
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Endothelial progenitor cellsA new key for endothelial dysfunction in migraineXiana Rodríguez-Osorio, Tomás Sobrino, David Brea et al.Neurology, July 18, 2012 -
Articles
Vascular endothelial growth factor in CSFA biological marker for carcinomatous meningitisG. Stockhammer, W. Poewe, S. Burgstaller et al.Neurology, April 25, 2000 -
Articles
Elevated serum angiogenin levels in ALSS. Cronin, M. J. Greenway, S. Ennis et al.Neurology, November 27, 2006 -
Views & Reviews
A developmental and genetic classification for malformations of cortical developmentA. J. Barkovich, R. I. Kuzniecky, G. D. Jackson et al.Neurology, September 28, 2005